One Size Does Not Fit All
The traditional model of prescribing — the same drug at the same dose for everyone with a condition — ignores the substantial genetic variation that influences how individuals metabolize and respond to medications. Precision medicine seeks to tailor treatment to individual characteristics, and pharmacogenomics — the study of how genes affect drug response — is one of its most immediately practical applications. Genetic differences explain why a medication that works well for one person may be ineffective or dangerous for another.
How Genes Shape Drug Response
Variations in genes encoding drug-metabolizing enzymes, transporters, and targets affect how quickly a drug is broken down, how much reaches its target, and how strongly it acts. Some people are rapid metabolizers who clear certain drugs too quickly for effect; others are poor metabolizers who accumulate drugs to toxic levels. Established examples include genetic testing before certain chemotherapy agents, blood thinners, and drugs where genetic variants substantially affect safety and dosing, helping avoid adverse reactions and treatment failures.
Toward Routine Use
Pharmacogenomic testing is gradually moving toward broader clinical use, with some health systems implementing preemptive testing that provides genetic information to guide future prescribing across a patient lifetime. Challenges remain in evidence generation, clinical decision support, cost, and integrating genetic data into practice. As sequencing costs fall and evidence accumulates, matching medications to individual genetic profiles promises safer, more effective prescribing — a concrete realization of precision medicine potential. Facilities can source lab supplies and diagnostic equipment from our catalog.
